Publications by authors named "Yuning Liao"

Claim this Profile
W
WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.
Hongbiao Huang, Yujie Xiang, Yuanfei Deng, Qing Liu, Gengxi Cai, Yuning Liao

Oncogene· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAND1 mediates CUL7-dependent HER2 protein stability to drive breast cancer progression.
Xiaohong Xia, Xiaoyue He, Mengfan Tang, Yuanlin Chen, Yuning Liao

Breast Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The deubiquitinase USP7 stabilizes HER2 expression and promotes breast cancer progression.
Xiaoyue He, Xiaohong Xia, Ziying Lei, Mengfan Tang, Jiangyu Zhang, Yuning Liao

Neoplasia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer.
Hongbiao Huang, Xuefen Zhuang, Shusha Yin, Wenshuang Sun, Ji Cheng, Yuning Liao

Oncogene· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ku70 targets BRD3-MYC/Cyclin D1 axis to drive hepatocellular carcinoma progression.
Wenshuang Sun, Ji Cheng, Ruijun Zhao, Yujie Xiang, Yuting Li, Yuning Liao

Exp Cell Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
METTL14-mediated mA modification enhances USP22-ERα axis to drive breast cancer malignancy.
Xuefen Zhuang, Shusha Yin, Ji Cheng, Wenshuang Sun, Zesen Fang, Yuning Liao

Pharmacol Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration.
Zhenlong Shao, Shutong Liu, Wenshuang Sun, Xuefen Zhuang, Shusha Yin, Yuning Liao

Cell Mol Biol Lett· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laser Acupuncture versus Liraglutide in Treatment of Obesity: A Multi-Institutional Retrospective Cohort Study.
Wen-Lin Yu, Yu-Ning Liao, Tsung-Hsien Yang, Ching-Wei Yang, Ting-I Kao

Healthcare (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma.
Yuning Liao, Yuan Liu, Cuifu Yu, Qiucheng Lei, Ji Cheng

Adv Sci (Weinh)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Chinese herbal medicine is associated with higher body weight reduction than liraglutide among the obese population: a real-world comparative cohort study.
Yu-Ning Liao, Hsing-Yu Chen, Ching-Wei Yang, Pai-Wei Lee, Chiu-Yi Hsu

Front Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16.
Yuan Liu, Wei-Yao Kong, Cui-Fu Yu, Zhen-Long Shao, Qiu-Cheng Lei, Yu-Ning Liao

Acta Pharmacol Sin· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression.
Xiaohong Xia, Tumei Hu, Xiaoyue He, Yuan Liu, Cuifu Yu, Yuning Liao

Int J Biol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese herbal medicine is associated with higher body weight reduction than liraglutide among the obese population: A real-world comparative cohort study.
Yu-Ning Liao, Hsing-Yu Chen, Ching-Wei Yang, Pai-Wei Lee, Chiu-Yi Hsu

Front Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A SIX1 degradation inducer blocks excessive proliferation of prostate cancer.
Yuning Liao, Wenshuang Sun, Zhenlong Shao, Yuan Liu, Xiaoyu Zhong

Int J Biol Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment.
Xiaohong Xia, Jinchan He, Bin Liu, Zhenlong Shao, Qiong Xu, Yuning Liao

Int J Biol Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective degradation of AR-V7 to overcome castration resistance of prostate cancer.
Yuan Liu, Cuifu Yu, Zhenlong Shao, Xiaohong Xia, Tumei Hu, Yuning Liao

Cell Death Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance.
Yuning Liao, Yuan Liu, Zhenlong Shao, Xiaohong Xia, Yuanfei Deng

Oncogene· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells.
Yuning Liao, Zhenlong Shao, Yuan Liu, Xiaohong Xia, Yuanfei Deng

J Exp Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling.
Yufan Tan, Xiaoyu Zhong, Xizhi Wen, Leyi Yao, Zhenlong Shao, Yuning Liao

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy.
Yuning Liao, Yuan Liu, Xiaohong Xia, Zhenlong Shao, Chuyi Huang

Theranostics· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression.
Xiaohong Xia, Chuyi Huang, Yuning Liao, Yuan Liu, Jinchan He

Cell Death Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
USP10 deletion inhibits macrophage-derived foam cell formation and cellular-oxidized low density lipoprotein uptake by promoting the degradation of CD36.
Xiaohong Xia, Tumei Hu, Jinchan He, Qiong Xu, Cuifu Yu, Yuning Liao

Aging (Albany NY)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERα is a target for butein-induced growth suppression in breast cancer.
Chuyi Huang, Xiaohong Xia, Jinchan He, Yuan Liu, Zhenlong Shao, Yuning Liao

Am J Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting SKP2/Bcr-Abl pathway with Diosmetin suppresses chronic myeloid leukemia proliferation.
Yuan Liu, Zhenlong Shao, Yuning Liao, Xiaohong Xia, Chuyi Huang

Eur J Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal Serum Bilirubin/Albumin Concentrations in Dementia Patients With Aβ Deposition and the Benefit of Intravenous Albumin Infusion for Alzheimer's Disease Treatment.
Xiaomei Zhong, Yuning Liao, Xinru Chen, Naikeng Mai, Cong Ouyang

Front Neurosci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis